SCHEDULE 13G

Amylyx Pharmaceuticals Inc

Common Stock, $0.0001 par value per share · CUSIP: 03237H101

Event date: 2025-01-13

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Point72 Asset Management, L.P.

  Shares: 4,820,333.00 · Class: 5.6%

• Point72 Capital Advisors, Inc.

  Shares: 4,820,333.00 · Class: 5.6%

• Steven A. Cohen

  Shares: 4,820,333.00 · Class: 5.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.